Episode 065: Breast Cancer Series, Pt. 10-ER+, Metastatic Breast Cancer
The Fellow on Call: The Heme/Onc Podcast
00:00
CDK4/6 Inhibitors and First-line Strategy
Biology and class toxicities of CDK4/6 inhibitors (-ciclib) and pivotal trials supporting first-line CDK4/6 plus non‑steroidal aromatase inhibitor to improve PFS.
Play episode from 16:16
Transcript
